Company News, Financial News

Coppertone to Bayer?

Merck's consumer healthcare unit valued at $14B.

Author Image

By: TOM BRANNA

Editor

German drugmaker Bayer AG is nearing an agreement to buy Merck & Co Inc's consumer healthcare unit, people familiar with the matter said, in a deal that could value the business at around $14 billion. Bayer edged out other rival bidders in the auction, including Procter & Gamble Co, Boehringer Ingelheim, Novartis AG and Sanofi SA, according to Bloomberg. Reckitt Benckiser Group, one of the final contenders in the auction, said on Wednesday it was no longer in active talks to buy t...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters